The 7th annual conference of the Indian Society for Clinical Research
(ISCR) will be held in Bangalore on January 10-11, 2014. The theme of
the two-day event is 'Research at Crossroads', a theme reflective of the
increasing challenges being faced by the clinical research fraternity
across the stakeholder spectrum.The event will see leading
clinical research experts from academia, healthcare institutions and the
industry deliberate on the state of clinical research in India.
Distinguished academician and clinical pharmacologist, Prof. Ranjit Roy
Chaudhury who was earlier this year invited by the government to lead an
Expert Committee to submit recommendations to the Ministry of Health on
strengthening the regulatory environment for clinical research in
India, will be the Guest of Honour at the event.Over the two
days, clinical research professionals will lead discussions on various
aspects of clinical research including the regulatory environment and
compensation, accreditation, emerging opportunities in clinical research
and the challenges and opportunities for stakeholders.“While
there has been a lot of progress in the development of new medicines for
life threatening diseases made possible through clinical research, in
recent years India has seen a lot negativity around the conduct of
clinical research in the country, fueled by activism and
misunderstanding. In addition, we have witnessed uncertainty and
unpredictability in the regulatory environment, all of which has led to a
slowdown in clinical research in the country,” said Suneela Thatte,
president, ISCR. “The Conference will provide an opportunity for
clinical research professionals to converge and discuss how we can
address the current challenges so that patients in India, particularly
those suffering from debilitating and life-threatening conditions, are
not denied access to better treatment or a cure.”ISCR is an
association of clinical research professionals that aims to build
awareness of clinical research as a specialty in India and to facilitate
its growth in the country while helping to evolve the highest standards
of quality and ethics.
Source:Pharmabiz
Source:Pharmabiz
No comments:
Post a Comment